Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 118 of 118 entries
View as:

A Clinical Study to Assess Next-day Driving Performance Following Administration of ACT-541468 in Middle-aged and Elderly Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03892902 Org: User:
Start: 03/25/19 End: 10/10/19 Due: 10/10/20

Study to Validate the Questionnaire Called IDSIQ™ in Patients With Insomnia Disorder

Phase: N/A Priority: Normal
NCT ID: NCT03056053 Org: User:
Start: 02/15/17 End: 05/05/17 Due: 05/05/18

Effect of Cimetidine on the Pharmacokinetics of Lucerastat in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03380455 Org: User:
Start: 01/09/18 End: 01/29/18 Due: 01/29/19

A Study to Investigate the Effect of ACT-132577 on the Pharmacokinetics of Midazolam and 1-hydroxy Midazolam in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02841761 Org: User:
Start: 07/01/16 End: 10/01/16 Due: 10/01/17

Pharmacokinetic Interaction Between Midazolam and ID-082 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03363984 Org: User:
Start: 11/27/17 End: 12/19/17 Due: 12/19/18

Study in Healthy Subjects to Examine the Safety and Tolerability of ACT-1004-1239 Given as Multiple, Gradually Increasing Doses and to Examine the Effects of ACT-1004-1239 on the Body and the Way the Body Takes up, Distributes, and Gets Rid of ACT-1004-1239

Phase: N/A Priority: Normal
NCT ID: NCT04286750 Org: User:
Start: 07/11/20 End: 09/25/20 Due: 09/25/21

Clinical Study to Explore the Efficacy of ACT-129968 in Patients With Partly Controlled Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01225315 Org: User:
Start: 11/01/10 End: 02/01/12 Due: 02/01/13

Study to Assess the Long Term Safety and Tolerability of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep

Phase: N/A Priority: Normal
NCT ID: NCT03679884 Org: User:
Start: 10/09/18 End: 02/22/21 Due: 02/22/22

A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease

Phase: N/A Priority: Normal
NCT ID: NCT03384966 Org: User:
Start: 01/24/18 End: 09/18/18 Due: 09/18/19

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of ACT-1004-1239 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03869320 Org: User:
Start: 03/25/19 End: 07/11/19 Due: 07/11/20

The Effect of Reduced Liver Function on Selatogrel Pharmacokinetics

Phase: N/A Priority: Normal
NCT ID: NCT04406896 Org: User:
Start: 07/22/20 End: 10/23/20 Due: 10/23/21

Selatogrel Outcome Study in Suspected Acute Myocardial Infarction

Phase: N/A Priority: Normal
NCT ID: NCT04957719 Org: User:
Start: 08/14/21 End: 08/13/25 Due: 08/13/26

A Placebo-controlled Phase 1 Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Single- and Multiple-ascending Doses of ACT-1014-6470 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04608513 Org: User:
Start: 11/16/20 End: 09/20/21 Due: 09/20/22

Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of ACT-389949

Phase: N/A Priority: Normal
NCT ID: NCT02099071 Org: User:
Start: 11/30/11 End: 05/31/12 Due: 05/31/13

A Study to Measure Daridorexant in Breast Milk of Healthy Lactating Women

Phase: N/A Priority: Normal
NCT ID: NCT05632393 Org: User:
Start: 01/16/23 End: 04/30/23 Due: 04/30/24

Bioequivalence Study of Different Aprocitentan Tablet Formulations

Phase: N/A Priority: Normal
NCT ID: NCT05196399 Org: User:
Start: 02/02/22 End: 04/07/22 Due: 04/07/23

Tezosentan in Pulmonary Arterial Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01077297 Org: User:
Start: 08/31/10 End: 09/30/11 Due: 09/30/12

Clazosentan in Aneurysmal Subarachnoid Hemorrhage

Phase: N/A Priority: Normal
NCT ID: NCT00940095 Org: User:
Start: 07/01/09 End: 01/01/11 Due: 01/01/12